<i>In situ</i>bioprinting: bioprinting methods, bioinks, cell sources & advanced bioprinting strategies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41582830.
- Also identified by DOI 10.1088/1758-5090/ae3cc3.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bioprinting is a tissue engineering approach which has great potential to devise regenerative therapies and alleviate tissue/organ shortage.<i>In situ</i>bioprinting, allowing the direct creation of functional 3D tissues/organs at the defect site in the patient body, has attracted significant attention of surgeons and researchers. However, it is challenging to design adequate combinations of manufacturing devices, bioinks and cells to meet the<i>in situ</i>bioprinting requirements of medical functions, complex human body environment and clinical applications. This review highlights current state-of-art bioprinting technologies, summarising their advantages and challenges for<i>in situ</i>applications from four perspectives: bioprinting methods, bioinks, cell sources and advanced bioprinting strategies.
Medical subject headings
- Bioprinting
- Tissue Engineering
- Ink